000 01203 a2200349 4500
005 20250514232609.0
264 0 _c20060125
008 200601s 0 0 eng d
022 _a1465-542X
024 7 _a10.1186/bcr1272
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColditz, Graham A
245 0 0 _aMenopausal hormone therapy after breast cancer.
_h[electronic resource]
260 _bBreast cancer research : BCR
_c2005
300 _a168-70 p.
_bdigital
500 _aPublication Type: Comment; Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHormone Replacement Therapy
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xetiology
650 0 4 _aPostmenopause
650 0 4 _aProgestins
_xadverse effects
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRisk Factors
650 0 4 _aTamoxifen
_xtherapeutic use
773 0 _tBreast cancer research : BCR
_gvol. 7
_gno. 4
_gp. 168-70
856 4 0 _uhttps://doi.org/10.1186/bcr1272
_zAvailable from publisher's website
999 _c15644713
_d15644713